Invitrogen created an advisory board last week for its biodefense research unit. David Franz, the chief biological scientist at Midwest Research Institute in Frederick, Md; and director of the National Agricultural Biosecurity Center at Kansas State University was appointed chairman. Those appointed as directors of the advisory board were: Margaret Hamburg, the vice president of biological programs of the Washington, D.C.-based Nuclear Threat Initiative; Stephen Albert Johnson, director of the Center for Biomedical Inventions based in Dallas; Scott Lillibridge, director for the Center for Biosecurity and Public Health Preparedness, based in Houston; and C J Peters, the director of Biodefense at the University of Texas Medical Branch Center for Biodefense and Emerging Infectious Diseases, based in Galveston, Texas.
GE Healthcare Biosciences has named Peter Ehrenheim president of protein separations, a role he initially assumed for Amersham in 1999. Ehrenheim has served as vice president for North American manufacturing for Amersham Pharmacia Biotech. He holds an MSc in mechanical engineering from the Royal Institute of Technology in Stockholm, Sweden.
Anthony Martin has been appointed to the board of directors of Windsor, Conn.-based Protedyne. Martin previously served as chairman and CEO of Molecular Probes.